Jorge Ruiz-Medrano - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jorge Ruiz-Medrano

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

JCI Insight|June 24, 2025

LRP2 is a potential molecular target for nonsyndromic pathological myopiaKimberley Delaunay, Emilie Picard, Patricia Lassiaz, et al.

The British Journal of Ophthalmology|May 16, 2025

Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric studyJorge Ruiz-Medrano, Patricia Udaondo Mirete, Marina Fernández-Jiménez, et al.

Plos One|July 31, 2020

Genetic and environmental factors related to the development of myopic maculopathy in Spanish patientsValentina Bilbao-Malavé, Sergio Recalde, Jaione Bezunartea, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

JCI Insight|June 24, 2025

LRP2 is a potential molecular target for nonsyndromic pathological myopiaKimberley Delaunay, Emilie Picard, Patricia Lassiaz, et al.

The British Journal of Ophthalmology|May 16, 2025

Plos One|July 31, 2020

Genetic and environmental factors related to the development of myopic maculopathy in Spanish patientsValentina Bilbao-Malavé, Sergio Recalde, Jaione Bezunartea, et al.

Pageof 6